Aligned Bio raised $3.6m for detection platform.
The funding will support commercializing its nanowire-based single-molecule detection platform for ultra-sensitive immunoassays and next-generation sequencing.
See the latest news and media coverage for Aligned Bio. We track all announcements, press releases, and industry mentions in real time, all in one place.
Nanowire biosensor and nucleic acid sequencing company
alignedbio.comLast updated
In short: Aligned Bio raised $3.6 million to commercialize its nanowire-based single-molecule detection platform and scale up its technology.
The funding will support commercializing its nanowire-based single-molecule detection platform for ultra-sensitive immunoassays and next-generation sequencing.
A poster details experimental results and methods presented at ADLM '25 in Chicago, with a downloadable PDF available.
They leverage microfluidics expertise for assay development and system integration in diagnostic workflows.
It alleviates SBS phasing errors, extending reads from 150-200 bp to 1000-2000 bp at Q40-Q30. This addresses clinical applications in DeciBio's report.
Swedish biotech startup Aligned Bio is betting on nanowire technology to turn existing sequencing-by-synthesis platforms into single-molecule sequencers. The Lund, Sweden-based company showcased ...
Lund, Sweden – SmiLe company Aligned Bio has successfully completed a financing round, securing SEK 19.4 million to accelerate the development and scale up its...
Track Aligned Bio and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Aligned Bio and other trending companies.